Hepatic Necrosis Due to Marsilid

Area of Science:

• Pharmacology
• Hepatology
• Clinical Toxicology

Background:

• Iproniazid (Marsilid) is a medication historically used as an antidepressant.
• Drug-induced liver injury (DILI) is a significant concern in clinical practice.
• Short-term drug administration can sometimes lead to severe adverse events.

Purpose of the Study:

• To report a case of severe jaundice and death linked to short-term iproniazide treatment.
• To emphasize the potential hepatotoxicity of iproniazide.
• To raise awareness regarding adverse drug reactions from antidepressants.

Main Methods:

• Case report detailing a patient's clinical course.
• Review of medication history and adverse events.
• Documentation of jaundice and fatal outcome.

Main Results:

• The patient developed severe jaundice after only three days of iproniazide administration.
• The jaundice progressed rapidly, leading to a fatal outcome.
• Hepatotoxicity was strongly suspected as the cause of death.

Conclusions:

• Iproniazid can cause severe, life-threatening hepatotoxicity, even with brief exposure.
• Clinicians should be vigilant for signs of liver injury in patients treated with iproniazide.
• This case underscores the importance of careful patient monitoring for adverse drug reactions.